» Authors » Esteban Urias

Esteban Urias

Explore the profile of Esteban Urias including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 320
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Goyal T, Song M, Suresh D, Jasty V, Urias E, Wijarnpreecha K, et al.
Dig Dis Sci . 2024 Oct; 69(11):4250-4258. PMID: 39407080
Background: In patients with metabolic dysfunction-associated steatotic liver disease (MASLD), there are limited data on how changes in FIB4 and liver stiffness measurement (LSM) correlate in non-biopsy cohorts. Aims: Our...
2.
Jasty V, Urias E, Tiong K, Aboona M, Song M, Faulkner C, et al.
Dig Dis Sci . 2024 Sep; 69(11):4240-4249. PMID: 39322805
Background/aims: Liver stiffness measurement (LSM) by vibration-controlled transient elastography (VCTE) is recommended for risk stratification of patients with nonalcoholic fatty liver disease (NAFLD). More recently, AGILE3 + and AGILE4 have...
3.
Urias E, Tedesco N, Burkholder D, Moran I, Miller M, Jasty V, et al.
Hepatol Commun . 2024 May; 8(6. PMID: 38780253
Background: The PNPLA3-rs738409-G, TM6SF2-rs58542926-T, and HSD17B13-rs6834314-A polymorphisms have been associated with cirrhosis, hepatic decompensation, and HCC. However, whether they remain associated with HCC and decompensation in people who already have...
4.
Noureldin M, Rubenstein J, Urias E, Berinstein J, Cohen-Mekelburg S, Saini S, et al.
Am J Gastroenterol . 2023 Nov; 119(5):830-836. PMID: 37975573
Introduction: Esophageal squamous cell carcinoma (ESCC) has a higher incidence and prevalence than esophageal adenocarcinoma among Black individuals in the United States. Black individuals have lower ESCC survival. These racial...
5.
Urias E, Tedesco N, Oliveri A, Raut C, Speliotes E, Chen V
Gastroenterology . 2023 Nov; 166(3):515-517.e2. PMID: 37972824
No abstract available.
6.
Wong Y, Urias E, Song M, Goyal T, Tay W, Han N, et al.
Hepatol Commun . 2023 Sep; 7(10). PMID: 37738409
Introduction: Noninvasive tests, such as Fibrosis-4 (FIB-4), liver-stiffness measurement (LSM) by vibration-controlled transient elastography, and Fibroscan-AST (FAST), are frequently used for risk stratification in NAFLD. The comparative performance of FIB-4...
7.
Urias E, Chen V
Semin Liver Dis . 2023 Apr; 43(2):133-141. PMID: 37105224
While nonalcoholic fatty liver disease is a leading cause of end-stage liver disease, most patients with nonalcoholic fatty liver disease do not develop cirrhosis and its complications. Therefore, risk stratification...
8.
Jiang C, Bhattacharya A, Linzey J, Joshi R, Cha S, Srinivasan S, et al.
Neurosurgery . 2022 Mar; 90(6):758-767. PMID: 35343469
Background: Accurate specimen analysis of skull base tumors is essential for providing personalized surgical treatment strategies. Intraoperative specimen interpretation can be challenging because of the wide range of skull base...
9.
Hollon T, Pandian B, Urias E, Save A, Adapa A, Srinivasan S, et al.
Neuro Oncol . 2020 Jul; 23(1):144-155. PMID: 32672793
Background: Detection of glioma recurrence remains a challenge in modern neuro-oncology. Noninvasive radiographic imaging is unable to definitively differentiate true recurrence versus pseudoprogression. Even in biopsied tissue, it can be...
10.
Khalsa S, Hollon T, Adapa A, Urias E, Srinivasan S, Jairath N, et al.
CNS Oncol . 2020 Jul; 9(2):CNS56. PMID: 32602745
The discovery of a new mass involving the brain or spine typically prompts referral to a neurosurgeon to consider biopsy or surgical resection. Intraoperative decision-making depends significantly on the histologic...